FIBROBLAST GROWTH-FACTOR-RECEPTOR-1 AND GROWTH-FACTOR-RECEPTOR-2 ARE DIFFERENTIALLY REGULATED IN MURINE EMBRYONAL CARCINOMA-CELLS AND IN RESPONSE TO FIBROBLAST GROWTH-FACTOR-IV

被引:14
作者
ALI, J
MANSUKHANI, A
BASILICO, C
机构
[1] NYU,SCH MED,DEPT MICROBIOL,NEW YORK,NY 10016
[2] NYU,SCH MED,KAPLAN CANC CTR,NEW YORK,NY 10016
关键词
D O I
10.1002/jcp.1041650225
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
We have studied the expression of two of the receptors for fibroblast growth factors, FGFR-1 and FCFR-2, in response to ligand binding and in embryonal carcinoma (EC cells). Exposure of mouse fibroblasts to FGF-4 or FGF-2 results in a drastic downregulation of the mRNA levels for FGFR-2, while expression of FCFR-1 mRNA appears unaffected. Furthermore, FCF-4 transformed cells display low levels of FCFR-2 mRNA and these levels are significantly increased by treatment with anti FGF-4 neutralizing antibodies. In undifferentiated F9 EC cells, the levels of FGFR-2 mRNA are very low and increase substantially upon induction of differentiation. The levels of mRNA for FGFR-1 are again unaffected. To gain information on the regulation of expression of the gene encoding FGFR-2 (bek) we have cloned the FGFR-2 promoter region and used it to drive the expression of plasmids encoding the bacterial CAT enzyme. Transfection of these plasmids into FGF treated and untreated cells did not produce significant variation in CAT activity, suggesting that FCFR-2 downregulation in response to ligand binding occurs mainly by a post-transcriptional mechanism. In contrast, plasmids containing as little as 140 nt of the FCFR-2 promoter region were regulated in F9 cells, showing substantially higher expression in differentiated than in undifferentiated cells. It appears therefore that FCFR-2 expression in fibroblasts and EC cells is regulated by somewhat different mechanisms. In contrast, FGFR-1 expression does not vary substantially under the conditions shown to affect FGFR-2 expression. The implications of these findings are discussed. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:438 / 448
页数:11
相关论文
共 37 条
[1]
Ausubel FM., 1995, MOL REPROD DEV, V3rd edn, DOI DOI 10.1002/MRD.1080010210
[2]
AVIVI A, 1992, ONCOGENE, V7, P1957
[3]
THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES [J].
BASILICO, C ;
MOSCATELLI, D .
ADVANCES IN CANCER RESEARCH, 1992, 59 :115-165
[4]
TRANSCRIPTION FACTORS THAT ACTIVATE THE ULTRABITHORAX PROMOTER IN DEVELOPMENTALLY STAGED EXTRACTS [J].
BIGGIN, MD ;
TJIAN, R .
CELL, 1988, 53 (05) :699-711
[5]
ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[6]
EPIDERMAL GROWTH-FACTOR REGULATES THE EXPRESSION OF ITS OWN RECEPTOR [J].
CLARK, AJL ;
ISHII, S ;
RICHERT, N ;
MERLINO, GT ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (24) :8374-8378
[7]
EXPRESSION OF THE K-FGF PROTOONCOGENE IS CONTROLLED BY 3' REGULATORY ELEMENTS WHICH ARE SPECIFIC FOR EMBRYONAL CARCINOMA-CELLS [J].
CURATOLA, AM ;
BASILICO, C .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (06) :2475-2484
[8]
INTERLEUKIN-2 (IL-2) AUGMENTS TRANSCRIPTION OF THE IL-2 RECEPTOR GENE [J].
DEPPER, JM ;
LEONARD, WJ ;
DROGULA, C ;
KRONKE, M ;
WALDMANN, TA ;
GREENE, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (12) :4230-4234
[9]
DYNAN WS, 1983, TRENDS GENET, V2, P196
[10]
COMPLEXITY OF FGF RECEPTORS - GENETIC-BASIS FOR STRUCTURAL DIVERSITY AND FUNCTIONAL SPECIFICITY [J].
GIVOL, D ;
YAYON, A .
FASEB JOURNAL, 1992, 6 (15) :3362-3369